Evidence map›Paper›PMID 37720707›Full record

ArticleClinical case reports2023

The necessity of proactive measures from healthcare providers highlighted by delayed breast cancer diagnosis due to COVID-19: A case report.

Yudai Kaneda, Akihiko Ozaki, Mira Namba, Toyoaki Sawano, Masahiro Wada, Hiroaki Saito, Yoshiaki Kanemoto, Tomohiro Kurokawa, Masaharu Tsubokura, Kazunoshin Tachibana and 5 more

Abstract readCase Reports
In one paragraph

Article in Clinical case reports, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed.

  1. Article
  2. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

15 authors.

Yudai KanedaSchool of Medicine Hokkaido University Sapporo Japan.ORCID https://orcid.org/0000-0001-8302-9439
Akihiko OzakiDepartment of Breast and Thyroid Surgery Jyoban Hospital of Tokiwa Foundation Iwaki Japan.ORCID https://orcid.org/0000-0003-4415-9657
Mira NambaSchool of Medicine Keio University Tokyo Japan.
Toyoaki SawanoDepartment of Surgery Jyoban Hospital of Tokiwa Foundation Iwaki Japan.
Masahiro WadaDepartment of Breast and Thyroid Surgery Jyoban Hospital of Tokiwa Foundation Iwaki Japan.
Hiroaki SaitoDepartment of Internal Medicine Soma Central Hospital Soma Japan.ORCID https://orcid.org/0000-0002-0824-454X
Yoshiaki KanemotoDepartment of Surgery Jyoban Hospital of Tokiwa Foundation Iwaki Japan.
Tomohiro KurokawaDepartment of Surgery Jyoban Hospital of Tokiwa Foundation Iwaki Japan.
Masaharu TsubokuraDepartment of Radiation Health Management Fukushima Medical University School of Medicine Fukushima Japan.ORCID https://orcid.org/0000-0001-8027-202X
Kazunoshin TachibanaDepartment of Breast Surgery Fukushima Medical University Fukushima Japan.
Tetsuya TanimotoDepartment of Internal Medicine Jyoban Hospital of Tokiwa Foundation Iwaki Japan.
Tohru OhtakeDepartment of Breast Surgery Fukushima Medical University Fukushima Japan.
Tomozo EjiriDepartment of Breast and Thyroid Surgery Jyoban Hospital of Tokiwa Foundation Iwaki Japan.
Hiroaki ShimmuraDepartment of Urology Jyoban Hospital of Tokiwa Foundation Iwaki Japan.
Norio KanzakiDepartment of Breast and Thyroid Surgery Jyoban Hospital of Tokiwa Foundation Iwaki Japan.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Key Clinical Message: During disasters, multiple factors can cause significant delays in medical visits. Regular patient monitoring, high-risk individual alerts, and telemedicine enhancements can potentially alleviate these issues and ensure timely interventions. Abstract: During the COVID-19 pandemic, a Japanese woman in her 70s delayed her regular breast cancer checkup for over 2 years. During disasters, health priorities tend to decline, necessitating proactive measures from healthcare providers, such as augmenting collaboration among healthcare professionals and identifying high-risk individuals.

Indexed as

breast cancerCOVID‐19disasterJapan

Identifiers

PMID37720707
PMCPMC10504424

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.